Atossa Therapeutics Investor Presentation 2021

Atossa Therapeutics is a clinical-stage biopharmaceutical company developing innovative medicines for oncology and infectious diseases, with a focus on breast cancer and COVID-19. The presentation outlines the company's development pipeline including candidates like Endoxifen, AT-301, and AT-H201, along with clinical trial progress and regulatory strategy.